Wednesday, November 18, 2026
Data from SEC filings, checked daily
My DeskFree
Public filings, plainly told
CEO Troy Edward Wilson buys $754,462 of Ku
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Nov 18, 2026·New filings added every weekday·Weekly prices as of Nov 20·What changed·
Insider purchase · Form 4 · Nov 16, 2026

CEO Troy Edward Wilson buys $754,462 of Kura Oncology, Inc. (KURA)

Troy Edward Wilson, chief executive, bought $754,462 of stock after a 21.1% fall. WallStPal Score 66.

66
WallStPal ScoreHow much this purchase says, from 0 to 100. How it works

Troy Edward Wilson, chief executive of Kura Oncology, Inc., bought 98,881 shares on the open market on November 13, 2026 at an average of $7.63 a share, for a total of $754,462. The purchase was reported to the SEC on Form 4 on November 16, 2026.

It raised their holding by 23%, to 534,337 shares.

The purchase came after a fall: Kura Oncology, Inc. stock was down 21.1% over the 13 weeks before.

Troy Edward Wilson last bought KURA on August 24, 2026.

In the 12 months up to this filing, Kura Oncology, Inc. insiders reported 4 open-market purchases and 24 sales.

WallStPal Score: 66 out of 100, because of raised their holding by 23%; outside their usual buying pattern; a large purchase; the stock had fallen 21.1% in the 13 weeks before; bought by a top executive.

It is too soon to say how the stock did afterward. This page will update as prices come in.

Our read

It is one of 4 insider purchases at KURA in the past year, made after a 21.1% fall in 13 weeks, a setup where insider buying has historically mattered most. It is worth reading next to the company's own results and news before drawing conclusions.

Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.

Examples

The only earlier insider purchase of Kura Oncology, Inc. in our records with a three-month result was by Troy Edward Wilson on September 8, 2025 ($410,145); the stock moved +28.7% over the following three months. One past purchase is not a pattern.

Explain it like I'm 13

Troy Edward Wilson helps run Kura Oncology, Inc.. Spending $754,462 of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.

More: all KURA insider trades · Troy Edward Wilson's track record

Sources

  1. Form 4: Troy Edward Wilson, purchase of KURA · filed 2026-11-16
  2. Form 4: Mollie Leoni, sale · filed 2026-09-29
  3. Form 4: Brian T. Powl, sale · filed 2026-09-29
  4. Form 4: Brian T. Powl, sale · filed 2026-09-29
  5. Form 4: Mollie Leoni, sale · filed 2026-09-29

The purchase filing and the other most recent Form 4 filings for the same company.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.